Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Is coronary artery disease complexity valuable in the prediction of contrast induced nephropathy besides Mehran risk score, in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention?

Aykan AÇ, Gül I, Gökdeniz T, Kalaycıoğlu E, Turan T, Boyacı F, Erkan H, Hatem E, Aykan DA, Celik S.

Heart Lung Circ. 2013 Oct;22(10):836-43. doi: 10.1016/j.hlc.2013.03.085. Epub 2013 Apr 28.

PMID:
23628329
2.

Utility of the Logistic Clinical Syntax Score in the Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention.

Ozturk D, Celik O, Erturk M, Kalkan AK, Uzun F, Akturk IF, Akin F, Yildirim A.

Can J Cardiol. 2016 Feb;32(2):240-6. doi: 10.1016/j.cjca.2015.05.005. Epub 2015 May 16.

PMID:
26255218
3.

Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

Andò G, Morabito G, de Gregorio C, Trio O, Saporito F, Oreto G.

Catheter Cardiovasc Interv. 2013 Nov 15;82(6):878-85. doi: 10.1002/ccd.25023. Epub 2013 Jun 27.

PMID:
23703775
4.

Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.

Oksuz F, Yarlioglues M, Cay S, Celik IE, Mendi MA, Kurtul A, Cankurt T, Kuyumcu S, Canpolat U, Turak O.

Am J Cardiol. 2015 Sep 1;116(5):711-6. doi: 10.1016/j.amjcard.2015.05.042. Epub 2015 Jun 4.

PMID:
26116992
5.

Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention.

Elbasan Z, Şahin DY, Gür M, Kuloğlu O, Kivrak A, Içen YK, Türkoglu C, Yildirim A, Özdogru I, Çayli M.

Angiology. 2014 Jan;65(1):37-42. doi: 10.1177/0003319712463816. Epub 2012 Oct 29.

PMID:
23109331
6.

Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.

Lucreziotti S, Centola M, Salerno-Uriarte D, Ponticelli G, Battezzati PM, Castini D, Sponzilli C, Lombardi F.

Int J Cardiol. 2014 Jun 1;174(1):37-42. doi: 10.1016/j.ijcard.2014.03.087. Epub 2014 Mar 20.

PMID:
24698233
7.

Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention.

Oduncu V, Erkol A, Karabay CY, Şengül C, Tanalp AC, Fotbolcu H, Özveren O, Bitigen A, Pala S, Kırma C.

Int J Cardiol. 2013 Oct 9;168(4):3480-5. doi: 10.1016/j.ijcard.2013.04.166. Epub 2013 May 17.

PMID:
23688433
8.

The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.

Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R.

Catheter Cardiovasc Interv. 2011 Aug 1;78(2):198-201. doi: 10.1002/ccd.22828. Epub 2010 Oct 14.

PMID:
20949583
9.

Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.

Pyxaras SA, Sinagra G, Mangiacapra F, Perkan A, Di Serafino L, Vitrella G, Rakar S, De Vroey F, Santangelo S, Salvi A, Toth G, Bartunek J, De Bruyne B, Wijns W, Barbato E.

Am J Cardiol. 2013 Mar 1;111(5):684-8. doi: 10.1016/j.amjcard.2012.11.018. Epub 2012 Dec 19.

PMID:
23261003
10.

Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?

Ballı M, Taşolar H, Çetin M, Hatem E, Çağlıyan ÇE, Şeker T, Çaylı M.

J Cardiol. 2016 Apr;67(4):327-30. doi: 10.1016/j.jjcc.2015.09.018. Epub 2015 Nov 14.

11.

High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.

Liu Y, Tan N, Zhou YL, Chen YY, Chen JY, Chen J, Luo JF.

J Nephrol. 2012 May-Jun;25(3):332-40. doi: 10.5301/jn.5000007.

PMID:
21928234
12.

SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.

Şahin DY, Gür M, Elbasan Z, Kuloğlu O, Şeker T, Kivrak A, Tanboğa İH, Gözübüyük G, Kirim S, Çayli M.

Coron Artery Dis. 2013 Mar;24(2):148-53. doi: 10.1097/MCA.0b013e32835c4719.

PMID:
23363986
13.

Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.

Wickenbrock I, Perings C, Maagh P, Quack I, van Bracht M, Prull MW, Plehn G, Trappe HJ, Meissner A.

Clin Res Cardiol. 2009 Dec;98(12):765-72. doi: 10.1007/s00392-009-0058-5. Epub 2009 Oct 23.

PMID:
19851800
14.

Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty.

Ivanes F, Isorni MA, Halimi JM, Fauchier L, Saint Etienne C, Babuty D, Angoulvant D, Brunet-Bernard A.

Arch Cardiovasc Dis. 2014 Aug-Sep;107(8-9):424-32. doi: 10.1016/j.acvd.2014.05.008. Epub 2014 Jul 28.

15.

Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.

Jian-Wei Z, Yu-Jie Z, Shu-Jun C, Qing Y, Shi-Wei Y, Bin N.

Angiology. 2014 May;65(5):402-7. doi: 10.1177/0003319713482177. Epub 2013 Mar 28.

PMID:
23539615
16.
17.

Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.

Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO.

Circ Cardiovasc Interv. 2014 Apr;7(2):216-24. doi: 10.1161/CIRCINTERVENTIONS.113.000653. Epub 2014 Apr 8.

18.

Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI.

Sağ S, Yıldız A, Aydin Kaderli A, Gül BC, Bedir Ö, Ceğilli E, Özdemir B, Can FE, Aydınlar A.

Clin Chem Lab Med. 2017 Jan 1;55(1):132-138. doi: 10.1515/cclm-2016-0005.

PMID:
27331308
19.

N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.

Goussot S, Mousson C, Guenancia C, Stamboul K, Brunel P, Brunet D, Touzery C, Cottin Y, Zeller M.

Am J Cardiol. 2015 Sep 15;116(6):865-71. doi: 10.1016/j.amjcard.2015.06.007. Epub 2015 Jun 25.

PMID:
26183794
20.

Neutrophil-to-lymphocyte ratio predicts contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.

Kaya A, Kaya Y, Topçu S, Günaydin ZY, Kurt M, Tanboğa IH, Kalkan K, Aksakal E.

Angiology. 2014 Jan;65(1):51-6. doi: 10.1177/0003319713484789. Epub 2013 Apr 25.

PMID:
23620308

Supplemental Content

Support Center